Breaking News
WEBINAR | Official Launch of TIF’s Nutrition Guidelines in Thalassaemia and PKD
EXCITING ADVANCEMENTS IN BLOOD TRAΝSFUSION THERAPY | FDA Approves Hemanext ONE®
WEBINAR | Haemoglobin Disorders and EU Health Policies, 21 September 2023
IN THE SPOTLIGHT | Explore Our Latest Work in the TIF Newsletter, August Edition
CLINICAL NEWS | FDA Approves Luspatercept for First-line Treatment of Anemia in Lower-Risk MDS
TIF European Health Policy Webinar Series | 21 September 2023
PUBLICATIONS | Nutrition Guidelines in Thalassemia & PKD
TIF2023 | 16th International Conference on Thalassaemia & Haemoglobinopathies, November 3-5
DRUGS | EU Pulls Authorization of Adakveo for Sickle Cell Disease
COLD AGGLUTININ DISEASE | Enjaymo Improved Life Quality in Patients for 2.5 Years
English
Ελληνικά
Français
Deutsch
Italiano
العربية
English
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic & TIF
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
LeaveNoPatientBehind
LeaveNoPatientBehind
News
November 10, 2020
Leave No Patient Behind: A TIF Declaration For Access To Health At The Time of The COVID-19 Pandemic
Download the TIF Declaration HERE
Read More »
Back to top button
Close
Search for